Literature DB >> 15007617

Cardiac spectroscopy: techniques, indications and clinical results.

Meinrad Beer1.   

Abstract

Cardiac MR spectroscopy allows the non-invasive assessment of metabolic processes. In contrast to numerous experimental applications, the clinical use of MRS is still restricted to specialized centers of expertise. However, during the last 10 years, several technical improvements as well as new clinical applications have been introduced, which might change this fact. This article focuses on (1) these recent technical advances such as reproducible quantification methods and dedicated data acquisition as well as postprocessing methods, (2) outlines emerging clinical indications and (3) summarizes available clinical studies. Basic principles of cardiac metabolism are presented, and discussed in the context of recent clinical papers. Finally, the impact of the new highest-field magnets--3 T and beyond--is discussed under the perspectives for the future clinical role of MR spectroscopy.

Mesh:

Year:  2004        PMID: 15007617     DOI: 10.1007/s00330-004-2279-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  76 in total

1.  Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI.

Authors:  R Pohmann; M von Kienlin
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

Review 2.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

3.  Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans.

Authors:  M Beer; J Sandstede; W Landschütz; M Viehrig; K Harre; M Horn; M Meininger; T Pabst; W Kenn; A Haase; M von Kienlin; S Neubauer; D Hahn
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

4.  Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation.

Authors:  Hildo J Lamb; Hugo P Beyerbacht; Albert de Roos; Arnoud van der Laarse; Hubert W Vliegen; Ferre Leujes; Jeroen J Bax; Ernst E van der Wall
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094

5.  Proceedings: Living muscle studied by 31P nuclear magnetic resonance.

Authors:  J Dawson; D G Gadian; D R Wilkie
Journal:  J Physiol       Date:  1976-06       Impact factor: 5.182

6.  Bioenergetics. Dissecting the role of creatine kinase.

Authors:  T Wallimann
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

7.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

8.  Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging.

Authors:  J A den Hollander; W T Evanochko; G M Pohost
Journal:  Magn Reson Med       Date:  1994-08       Impact factor: 4.668

9.  Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries.

Authors:  M A Greenberg; R M Grose; N Neuburger; R Silverman; J E Strain; M V Cohen
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

10.  The creatine kinase system in normal and diseased human myocardium.

Authors:  J S Ingwall; M F Kramer; M A Fifer; B H Lorell; R Shemin; W Grossman; P D Allen
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

View more
  7 in total

1.  Energetic differences between viable and non-viable myocardium in patients with recent myocardial infarction are not an effect of differences in wall thinning- a multivoxel (31)P-MR-spectroscopy and MRI study.

Authors:  Meinrad Beer; Wolfram Machann; Jörn Sandstede; Stefan Buchner; Claudia Lipke; Herbert Köstler; Reinhard Lorenz; Kerstin Harre; Matthias Spindler; Dietbert Hahn
Journal:  Eur Radiol       Date:  2006-11-18       Impact factor: 5.315

2.  MR proton spectroscopy for myocardial lipid deposition quantification: a quantitative comparison between 1.5T and 3T.

Authors:  Bharath Ambale Venkatesh; Joao A C Lima; David A Bluemke; Shenghan Lai; Charles Steenbergen; Chia-Ying Liu
Journal:  J Magn Reson Imaging       Date:  2012-07-23       Impact factor: 4.813

3.  Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant.

Authors:  Rossana Malatesta-Muncher; Janaka Wansapura; Michael Taylor; Diana Lindquist; Kan Hor; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2012-02-23       Impact factor: 3.714

4.  Clinical applications for cardiovascular magnetic resonance imaging at 3 tesla.

Authors:  Allison G Hays; Michael Schär; Sebastian Kelle
Journal:  Curr Cardiol Rev       Date:  2009-08

5.  31P-MR spectroscopic imaging in hypertensive heart disease.

Authors:  J-P Heyne; R Rzanny; A Hansch; U Leder; J R Reichenbach; W A Kaiser
Journal:  Eur Radiol       Date:  2006-03-02       Impact factor: 5.315

6.  Magnetic resonance spectroscopy studies of human metabolism.

Authors:  Douglas E Befroy; Gerald I Shulman
Journal:  Diabetes       Date:  2011-05       Impact factor: 9.461

7.  An investigation into potential gender-specific differences in myocardial triglyceride content assessed by 1H-Magnetic Resonance Spectroscopy at 3Tesla.

Authors:  Bernhard Petritsch; Herbert Köstler; Tobias Gassenmaier; Andreas S Kunz; Thorsten A Bley; Michael Horn
Journal:  J Int Med Res       Date:  2016-04-18       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.